I came to Memorial Sloan Kettering in August 2008 from Sydney, Australia, where I had spent ten years as chief of a large academic palliative medicine program. I trained in internal medicine, palliative medicine, and pain medicine; and also served as a Fellow in palliative medicine at the Cleveland Clinic. My research interests include prognostication and the cancer cachexia (loss of body weight and muscle mass) syndrome. I am the associate editor of the new Palliative Medicine textbook published by Elsevier, and as well am editor of books on prognostication and on opioid pharmacology. I am co-chair of the Palliative Care section of the Multinational Association of Supportive Care in Cancer.
- Clinical Expertise: Pain Medicine; Palliative Medicine
- Languages Spoken: English
- Education: MD, University of Sydney Medical School (Australia)
- Residencies: Sydney Hospital; Royal Prince Alfred Hospital (Australia)
- Fellowships: Royal Prince Alfred Hospital; Eversleigh Hospital (Australia); Cleveland Clinic Hospital (US)
- Board Certifications: Australia: General (Internal) Medicine; Palliative Medicine; Pain Medicine
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more